Abstract
Efficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia: A Meta-analysis from Randomized Controlled Trials
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have